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ABSTRACT
PURPOSE: There is a growing scientific interest in the plasticity and therapeutic potential of adipose-derived stem cells (ASCs), which 
are multipotent and abundant in adipose tissue and can differentiate in vitro into multiple lineages, including adipocytes, chondrocytes, 
osteoblasts, neural cells, endothelial cells and cardiomyocytes. The aim of this study was to isolate, cultivate and identify ASCs. 
METHODS: Human adipose precursor cells were obtained from subcutaneous abdominal tissue. Recently dispersed cells were 
separated by density centrifugation gradient, cultured and then analyzed. 
RESULTS: Human ASCs were able to replicate in our culture conditions. The cells maintained their phenotypes throughout the studied 
period on different passages confirming they suitability for in vitro cultivation. We also induced their adipogenic, osteogenic and 
chondrogenic differentiation, verifying their mesenchymal stem cells potentiality in vitro. Flow cytometry results showed that these 
cells expressed CD73, CD90 and CD105, (mesenchymal stem-cells markers), contrasting with the lack of expression of CD16, CD34 
and CD45 (hematopoietic cells markers). 
CONCLUSION: It was possible to isolate human adipose-derived stem cells by in vitro cultivation without adipogenic induction, 
maintaining their functional integrity and high proliferation levels. The cells demonstrated adipogenic, osteogenic and chondrogenic 
differentiation potential in vitro.
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RESUMO
OBJETIVO: Há um interesse científico crescente na plasticidade e potencial terapêutico das células-tronco do tecido adiposo humano, 
células multipotentes e abundantes no tecido adiposo que podem se diferenciar in vitro em múltiplas linhagens celulares, incluindo 
adipócitos, condrócitos, osteoblastos, células neurais, endoteliais e cardiomiócitos. O objetivo deste estudo foi isolar, cultivar e identificar 
células-tronco do tecido adiposo humano.
MÉTODOS: Células precursoras humanas do tecido adiposo foram obtidas de tecido abdominal subcutâneo. As células recém-dispersas 
foram separadas por gradiente de centrifugação por densidade, cultivadas e então analisadas. 
RESULTADOS: As células-tronco do tecido adiposo humano foram capazes de se replicar nas nossas condições de cultivo e mantiveram 
seu fenótipo em diferentes passagens durante o estudo, confirmando sua adequabilidade para cultivo in vitro. A diferenciação adipogênica, 
osteogênica e condrogênica também foi induzida, confirmando seu potencial de células-tronco mesenquimais in vitro. Os resultados de 
citometria de fluxo evidenciaram a expressão dos marcadores de células-tronco mesenquimais CD73, CD90 e CD105, contrastando com 
a falta de expressão dos marcadores de células hematopoiéticas CD16, CD34 e CD45. 
CONCLUSÃO: Foi possível isolar células-tronco do tecido adiposo humano por cultivo in vitro sem indução adipogênica, mantendo 
sua integridade funcional e altos níveis de proliferação. As células demonstraram potencial de diferenciação adipogênico, osteogênico 
e condrogênico in vitro.
Descritores: Adipócitos. Células-Tronco Adultas. Células-Tronco Mesenquimais. Células-Tronco. Tecido Adiposo.
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Introduction
Tissue reconstruction in patients with loss of substance 
of mesenchymal origin like fat, bone and muscle due to trauma, 
tumor resection or vascular damage, represents a clinical problem 
of difficult solution. In these cases, the use of autologous tissue to 
reconstruct soft parts is of great importance1-6.
Two cell types are generally considered for this purpose: 
progenitor cells and stem cells. These cells present some limitations 
such as their diminished cell proliferation potential as the donor 
gets older and the low number of cells that can be collected7-10. 
On the other hand, the therapeutic potential of adult stem cells is 
enormous due to their self-renewal ability and multipotentiality. 
Adult stem cells are immunocompatible due to their autologous 
nature and their use does not involve ethical issues11-15. Bone 
marrow mesenchymal stem cells can be representative of this 
type due to their adipogenic, osteogenic, chondrogenic, myogenic 
and neurogenic potential in vitro16-20. There is a growing scientific 
interest in the plasticity and therapeutic potential of Human 
Adipose-Derived Stem Cells (ASCs). ASCs are multipotent and 
abundant in adipose tissue and they can differentiate in vitro into 
multiple lineages, including adipocytes, chondrocytes, osteoblasts, 
neural cells, endothelial cells and cardiomyocytes21.
The adipose tissue is the body’s major energy reserve, 
being almost ubiquitously distributed over the body and it shows an 
enormous plasticity throughout life. The main cellular components 
are mature, lipid-filled adipocytes, lipid-free preadipocytes and 
endothelial cells. Adipocytes are the only cells specialized in 
storing lipid in their cytoplasm as triacylglycerol without affecting 
their functional integrity22. When the energy balance is positive, 
extra calories are stored as triacylglycerol, which is achieved by 
enlargement of adipocytes, as well as via recruitment of committed 
progenitor cells to form more adipocytes23-24.
Correction of soft tissues by autologous fat graft is a 
common procedure in plastic surgery. Its efficacy and safety were 
considerably discussed and several lipoinjection techniques were 
developed25. However, this procedure must often be repeated due 
to resorption of the graft, which may occur because of the lack of 
nutritional support to the inner cell layers and because many of the 
injected cells are already differentiated26-27.
Autologous adipose cells are cultured so that only non-
differentiated, but committed, preadipocytes are grafted and 
this procedure can be done in a way that also ensures optimal 
nutritional support for the cells26-27.
The aim of this study was to isolate, cultivate and identify 
adipose-derived stem cells (ASCs).
Methods
Isolation of human adipose-derived stem cells (ASCs)
Adipose tissue samples were obtained from the 
subcutaneous abdominal tissue of ten adult female patients, aged 
32-49 years (mean=40 years old), submitted to abdominoplasty. 
Patients with inflammatory or malignant diseases were discarded. 
This research study was approved by the Research Ethics 
Committee of the Federal University of Sao Paulo and all patients 
signed a written free and informed consent form.
Cell isolation was done according to the method described 
by Hauner et al.28 with modifications. Briefly, after removal of all 
fibrous material and visible blood vessels, adipose tissue samples 
were cut into small pieces ( 10 to 20 mm) and digested in 10 
mM Phosphate- Buffered Saline (PBS) (Sigma Aldrich, St. Louis, 
Missouri, USA) containing 200 U/ml crude collagenase II (Sigma 
Aldrich, St. Louis, Missouri, USA) for 40 minutes in a shaking 
water bath at 37ºC. The dispersed material was filtered through 
a nylon mesh with a pore size of 150 μm. After centrifugation 
(300g), the mature adipocytes remained on the supernatant surface 
and the ASCs formed a pellet at the bottom of the tube. Ficoll-
hypaque (Histopaque®) was used as a centrifugation gradient for 
the separation of ASCs and the solution containing the pellet was 
resuspended in 3 ml of PBS. This solution was added to equal 
volumes of Histopaque® of different densities (1077 and 1119). 
The obtained mix was centrifuged (300g) for 30 minutes. Red 
blood cells (at the bottom of the tube) were, then, easily eliminated 
and the cells from the intermediate ring of the density gradient 
tube were used for both cytometric analyses and cultivation.
Culture and expansion
Cells were cultured in a standard medium composed 
by Dulbecco’s Modified Eagle’s Medium/Nutrient Mixture F-12 
Ham (DMEM/F12) (Sigma Aldrich, St. Louis, Missouri, USA), 
supplemented with 10% Fetal Bovine Serum (FBS) (Cultilab, 
Campinas-SP, Brazil), 100 U/ml penicillin (Sigma Aldrich, 
St. Louis, Missouri, USA) and 0.1 mg/ml streptomycin (Sigma 
Aldrich, St. Louis, Missouri, USA). The culture was maintained 
at 37ºC in humidified atmosphere of 95% O2 and 5% CO2. Cells 
were cultured for up to 6 passages, in triplicates. In each passage, 
1x106 cells were seeded to subconfluence in 75cm2 culture flasks 
for 7-10 days. 
When the cells attached to the flask reached approximately 
80% confluence, subculture (passage) was performed through 
enzymatic digestion (tripsinization). Cells were used from the 
second to the sixth passage. For the tripsinization the culture 
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medium was aspirated and the flask was washed using a PBS 
solution supplemented with ethylenediamine-tetra acetic acid 
(EDTA) (0.5M). The solution was then discarded and 3 ml of a 
solution composed by tripsin (0.25%) plus EDTA (0.02%) was 
added per flask and left for two minutes. The tripsin solution 
was neutralized using 3 ml complete DMEM/F12 medium. The 
cell suspension was centrifuged (300g, ten minutes) and its 
supernatant was aspirated. The pellet was resuspended in complete 
DMEM/F12 medium and cells were counted using the Trypan 
Blue exclusion test (hemocytometer). 1.0 x 106 cells were seeded 
in each new flask and the flasks were kept in humidified incubator 
(37ºC, 95% O2 and 5% CO2).
Differentiation assays
Adipogenic differentiation
For the adipogenic differentiation, cells were cultivated 
in 6-wells plates (TPP, Trasadingen, Schaffhausen, Switzerland) 
containing 2 ml of complete DMEM/F12 medium supplemented 
with 10 µM insulin and 1 µM dexamethasone (Sigma Aldrich, 
St. Louis, Missouri, USA) for 15 days (adipogenic medium). 
The plates were kept in humidified incubator (37ºC, 95% O2 and 
5% CO2) and the culture media was changed every three days. 
After this period, the medium was aspirated and the cells were 
washed twice with PBS. Then, 2 ml paraformaldehyde (Electron 
Microscopy Sciences) 0.4% in PBS was added to the cells. The 
fixative solution was aspirated after 30 minutes and the cells 
were washed three times with PBS as following: once with PBS 
containing Glycine 0.1 M for 10 minutes and twice with PBS for 
two minutes.
The cells were then incubated with Oil Red O dye 
(0.5%) at room temperature for 30 minutes. The dye was carefully 
removed with a 2 ml disposable pipette and the plate was washed 
five times with 2 ml water. The fixed and dyed cells were observed 
using Nikon Ti-U optical microscope and photographed using 
NIS-Elements - 3.2 Software (Nikon Instruments INC, New York).
Osteogenic differentiation 
For the osteogenic differentiation, the cells were cultured 
in six wells plates (TPP, Trasadingen, Schaffhausen, Switzerland) 
containing 2 ml complete DMEM/F12 medium supplemented 
with 50µM ascorbic acid (Sigma Aldrich, St. Louis, Missouri, 
USA), 0.1µM dexamethasone and 10-2M β glycerophosphate 
(Mallinckrodt Baker, Phillipsburg, New Jersey, USA) for 21 days 
(osteogenic medium). The plates were kept in humidified incubator 
(37ºC, 95% O2 and 5% CO2) and the culture media was changed 
every three days. After this period, the medium was aspirated 
and the cells were washed twice with PBS. Then, a solution of 
2 ml paraformaldehyde (Electron Microscopy Sciences) 0.4% in 
PBS was added to the cells. The fixative solution was aspirated 
after 30 minutes and the cells were washed three times with PBS 
as following: once with PBS containing Glycine 0.1 M for ten 
minutes and twice with PBS for two minutes.
The cells were then incubated in a solution of sodium 
alizarin (40nM, pH 4.1) (Sigma Aldrich, St. Louis, Missouri, 
USA) at room temperature for 30 minutes. The dye was carefully 
removed with a 2 ml disposable pipette and the plate was washed 
five times with 2 ml water. The fixed and dyed cells were observed 
using Nikon Ti-U optical microscope and photographed using the 
NIS-Elements - 3.2 Software (Nikon Instruments INC, New York).
Chondrogenic differentiation
For chondrogenic differentiation, the cells were cultured 
in six wells plates (TPP, Trasadingen, Schaffhausen, Switzerland) 
containing 2 ml complete DMEM/F12 supplemented with 10 µM 
insulin, 0.1 µM dexamethasone, 50µM ascorbic acid and 10ng/
ml TGF-β1 (Cell Signaling Technology, Beverly, Massachusetts, 
USA) for 21 days (chondrogenic medium). The plates were kept 
in humidified incubator (37ºC, 95% O2 and 5% CO2) and the 
culture media was changed every three days. After this period, the 
medium was aspirated and the cells were washed twice with PBS. 
Then the solution of 2 ml paraformaldehyde (Electron Microscopy 
Sciences) 0.4% in PBS was added to the cells. The fixative solution 
was aspirated after 30 minutes and the cells were washed three 
times with PBS as following: once with PBS containing Glycine 
0.1 M for ten minutes and twice with PBS for two minutes.
The cells were then incubated in a Toluidine Blue 
solution (0.1%) (Sigma Aldrich, St. Louis, Missouri, USA) at 
room temperature for 30 minutes. The dye was carefully removed 
with a 2 ml disposable pipette and the plate was washed five times 
with 2 ml of water. The fixed and dyed cells were observed using 
Nikon Ti-U optical microscope and photographed using the NIS-
Elements - 3.2 Software (Nikon Instruments INC, New York).
Immunophenotypic characterization of ASCs 
ASCs from the second passage were used for the 
immunophenotypic characterization. The cells were tripsinized and 
the cellular suspension was centrifuged (300g, 4 min). ASCs were 
stained with antibodies conjugated with fluorescein isothiocyanate 
(FITC), allophycocyanin (APC) or phycoerythrin (PE): CD16-PE, 
CD34-APC, CD45-FITC, CD73-PE, CD90-APC and CD105-PE 
(BD Biosciences, USA). A total of 5 x 105 cells were resuspended 
in 0.2 ml PBS and incubated with FITC-, APC- or PE-conjugated 
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antibodies for 20 minutes at room temperature and protected 
from light. The samples were analyzed by flow cytometry (Guava 
easyCyte, Millipore) for identification of specific fluorescence 
channels of each antibody.
Results
ACSs differentiation assays
ASCs were isolated using enzymatic digestion with 
collagenase. The cultivated cells of this study were evaluated from 
first to sixth passage and all cells showed morphology similar to 
fibroblasts with fusiform characteristics (Figure 1A).
Cell morphology was modified during adipogenic 
differentiation presenting lipid droplets on the cytoplasm after 
the first week of culture and stimulation with adipogenic medium. 
After two weeks of stimulation, big lipid inclusions were found 
in the cytoplasm, indicating the adipogenic capacity of this cells 
(Figure 1B), which was confirmed by Oil red staining.
The ASCs cultivated in osteogenic medium showed 
morphology similar to osteoblasts after 21 days of stimulation, 
with the presence of calcium precipitates, confirmed by alizarin 
red staining (Figure 1C).
When the ASCs were cultivated in chondrogenic 
medium during 21 days, the cells showed similar morphology to 
chondrocytes, evidenced by Toluidine Blue staining (Figure 1D).
FIGURE 1 - (A) ASCs are typical fibroblast-like cells with fusiform 
shape. Here they were obtained at the second passage (p2). (B) ASCs - 
adipogenic differentiation. Lipids detected by Oil Red O staining after two 
weeks induction. (C) ASCs - osteogenic differentiation. Calcium nodule 
formation demonstrated by Alizarin red stain after three weeks induction. 
(D) ASCs - chondrogenic differentiation demonstrated by Toluidin blue 
stain after three weeks induction.
Cell surface markers 
Cellular surface markers (CD) were utilized on second 
passage-cells to characterize the ASCs population. Flow cytometry 
results showed that these cells expressed CD73, CD90 and CD105, 
accepted as mesenchymal stem-cells markers, contrasting with the 
lack of expression of hematopoietic cells markers CD16, CD34 
and CD45 (Figure 2).
FIGURE 2 - Flow cytometry analysis. Cells from the second passage 
(P2) were positive for CD73-PE, CD90-APC, CD105-PE, with expression 
rates up to 95%, but negative for CD16-PE, CD34-APC and CD45-FITC. 
Discussion
Adipose tissue stem cells can be easily harvested from 
adipose tissue and expanded, with capacity of differentiation 
on multiple lineages in vitro21. Many adipose tissue stem cells 
isolation methods have been developed since Rodbell28, who 
demonstrated that adipocytes can be isolated from the stromal 
vascular fraction. It was showed later that this fraction contained a 
stem-cells population. However, it hasn’t yet been developed any 
efficient method to identify this cell population29. We showed in 
this paper a way to isolate this cell population using enzymatic 
digestion with collagenase and centrifugation gradient separation 
(fycoll) with subsequent cell proliferation and efficient potential of 
in vitro differentiation.
Mesenchymal stem cells do not have a specific marker, 
which invalidates the identification of these cells by specific 
antibodies. Instead, multiple markers are used together to 
identify this tissue21. In this study, we selected the following 
markers for the adipose tissue stem-cells identification: CD73, 
90, 105 (mesenchymal stem-cells markers) and CD16, 34 and 45 
(hematopoietic cells markers).
After the separation process, and at the 2nd passage of cell 
culture, the cells were also analyzed by flow cytometry (Figure 2). 
According to size (FSC) and complexity (SSC) parameters, only 
one population of cells was observed, in the ASCs region (figure 
2A), and flow cytometry analysis showed that the 2nd passage 
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cells were positive for CD73-PE, CD90-APC, CD105-PE, with 
expression rates up to 95%, but negative for CD16-PE, CD34-
APC and CD45-FITC, with a 3% rate. 
The cells maintained their phenotypes throughout the 
studied period on different passages, a fact that confirmed their 
suitability for in vitro cultivation. We also induced their adipogenic, 
osteogenic and chondrogenic differentiation, verifying their 
mesenchymal stem cells potentiality in vitro.
The morphological aspect of young cells with fusiform 
shape is a characteristic of ASCs (Figure 1) where multilocular 
lipid droplets can be identified in the cytoplasm due to the 
fat conversion occurring in these cells14-16. Such adipose cell 
characteristic, before forming a unique lipid inclusion, illustrates 
the adipocytes differentiation steps29. 
Conclusions
The adipose tissue stem cells can be efficiently isolated 
using the described methodology, kept similar morphology to 
fibroblasts when cultivated in the evaluated period and demonstrated 
adipogenic, osteogenic and chondrogenic differentiation potential 
in vitro. 
Our proposed method for cell culture following cell 
separation by density centrifugation gradient may provide the 
opportunity to characterize other adipogenic or anti-adipogenic 
factors related to adipose tissue expansion control. Of special 
interest is the fact that it was possible to isolate precursor cells 
of human adipose tissue, by in vitro cultivation, maintaining their 
functional integrity. 
Finally, we believe that the proposed model may add new 
knowledge about the lipid droplets biology, contributing to studies 
involving tissue engineering with quality and reproducibility.
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